Earlier in the day, the stock witnessed a breach early in the session. The stock was trading at a 52-week high price of Rs 3,248.0 and a 52-week low of Rs 2,311.3 in Yes. Around 8,860 stocks changed hands on the counter as of 12:49 PM (IST).
The stock opened at Rs 3140.95 and has touched an intraday high and low of Rs 3248.0 and Rs 3113.2 during the session so far. The counter traded a price-to-earnings (PE) ratio of 42.1, earnings per share (EPS) of Rs 74.52 and price to book value (PB) of 7.37, while return on equity (ROE) It stood at Rs 21.44.
Promoter / Holding FII
The promoters had a 71.25 percent stake in the company as of September 30, while the FII and MF properties stood at 13.28 percent and 6.66 percent, respectively.
Key finances
With a market capitalization of Rs 53086.01 crore, the company operates in the pharmaceutical industry - India. For the quarter ending June 30, 2021, the company reported consolidated sales of Rs 2,174 million, 10.02 percent more than Rs 1976.0 million in the previous quarter and 5.53 percent more than in the same quarter of the previous year. The company reported a net profit of Rs 330.0 crore for the latest quarter, up 2.8 percent from the corresponding quarter last year.
Technical indicators
The stock's Relative Strength Index (RSI) stands at 57.73. The RSI ranges between zero and 100. Traditionally, it is considered an overbought condition when the RSI value is above 70 and an oversold condition when it is below 30. Analysts say that the RSI indicator should not be viewed as In isolation, it may not be enough to accept a trade call, in the same way that a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation index.
